Mould contamination in pharmaceutical drug products and medial devices

T. Cundell, formerly of Merck Research Laboratories. European Pharmaceutical Review. Issue 6, Volume 18, 2013: pages 67-75. This email address is being protected from spambots. You need JavaScript enabled to view it.

Citation: “... Table 5 Comparison of Methods and Databases of Common Phenotypic and Genotypic Fungal Identification Systems … SmartGene Software... Conclusions … more attention should be given to the mitigation of the risk of fungal contaminiation of drug products and medical devices. … companies should upgrade their methods to include proteomic methods and rRNA base sequencing. ...”